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D92190 Influenceof RedWineandRedGrapeJuioaonLipidaandLipidPeroxidation
A.A. Schoanebarger, K. Schmidt, W. Maerz 1. KW3-/-fospit,/, 61462
Koenigstein, University Freibufg, Division of Clinical Chemist~, Department
of Medicine, Germany
A lower infarct rate with moderate alcohol consumption, especially with red
wine, has been shown in epidemiologic studies. Effects of alcohol on HDL-
Cholesterol and on lipid peroxidation have been postulated as mechanisms.
Therefore we examined the influence of moderate red wine consumption
(200 ml/day) on lipid metabolism and lipid peroxidation and the possible
influence of alcohol on a lipid lowering effect. After two weeks without con-
sumption of alcohol or grapes 24 healthy males (age 50 + 8 yeare) of normal
weight consumed in randomised fashion either 200 ml of red wine or 200
ml of red grape juice with their evening meals for 6 weeks. Blood samples
were taken on 2 consecutive days before and at the end of the 6 weeks.
Lipid peroxidation wasdeterminad by measuring the decrease of the content
of thiobarbituric acid reacting substances (TBARS) in response to copper
ions and the formation of conjugated dienes. Alcohol consumption was mea-
sured by self reporting and levels of carbohydrate deficient transferring(CDT).
Lipid levels were measured by standard laboratory tests. LDL-paroxidation
(TBARS and lag phase of diene formation) as well as the serum levels of
cholesterol (C), HDL-C, LDL-C, apolipoprotein (ape) Al, apo B, lipoprotein(a),
triglycerides, fibrinogen and platelets remained unchanged in troth groups.
Thromboplastin-time decreased from 92% to 65% (p = 0.004) in the red
wine group. The reporIed influence of high alcohol intake on lipid peroxida-
tion and HDL-C could not be found with moderate red wine consumption.
The mechanism of lower infarcts rates with moderate alcohol intake remains
unclear.
El92191 LDLSubclaasDistributionChangein FamilialCombinedHyperlipidemiaPatientsFollowing
GemflbrozilandNiacinTraatment
H.R. Superko, R.M. Krauss. Lawrence Berkeley National Laboratov,
University of California, Berkelex and Berkeley HeartLab, USA
Familial combined hyparlipidemia (FCH) is an inherited lipoprotein disorder
that is associated with increased CAD risk and a predominance of small,
dense LDL particles. The effects of gemfibrozil (G) and niacin (N) therapy
on LDL subclasses was investigated in 20 FCHL patients. After 6 wk of diet
stabilization, subjeots were randomized to placebo (P) or G (1,200 mg/d) for
12 wks and then niacin (1.500 m~d) was added to all subjects for 12 wks.
Lipoprotein mass concentrations were measured as a function of flotation
rate (Sf) in IDL (SI 12-20), large LDL (1,SI 7-12; H>Sf 5-7) and small LDL
(Ill, SI 3-5; IV, S~O-3). Changes in plasma lipid and lipoprotein levels from
baseline (mean + SD) for P and G groups (12 wks) were:
GrouP P (n = 10) G (n = 10) P VS.G (p)
Triglyceride –23 + 111 –189+ 97 0.001
HDL-Cholesterol 5+9 10* 12 0.23
LDL-Cholesterol 6 +27 –11 +27 0.15
IDL msss 1 &24 –29+20 0.002
LDL-I msss 11 l 22 16+58 0.82
LDL-11mass 16& 24 14+36 0,88
LDL-111mass –3 & 25 -32 +47 0.08
LDL4V maas -lo* 17 -16i17 0.38
With N + G, there was greater reduction in IDL (p = 0.06) and LDL41(p =
0.05) than with G alone.
Conclusion: Gemfibrozil therapy results in significant reductions in IDL
and small, dense LDL, but not LDL-C, in FCH. Addition of niacin results in
additional lipoprotein changes, including further reduction in IDL. Since IDL
levels are strongly related to angiographic progression of CAD, the results
suggest that G + N therapy maybe particularly effective in reducing CAD risk
in FCH.
1921-921 Cerivaatatin,aNewPotentHMG-CoAReductasa
Inhibitor:EfficacyandTolerabilityin Primary
Hypercholaaterolemia
W. Irwull 1, E. Steinz, E, Whalen, S. Ripa for the Cerivaatatin Study Group.
I Baylor-Methodist Lipid Research Clinic, Houaton, TX, USA, 2 Metabolic
and Atherosc/eroeis Research Centec Cincinnati, OH, USA
Cerivastatin (CER) is a novel, synthetic, potent, pure enantiomer and highly
selective HMG-COAreductase inhibitor, that effectively reduces cholesterol
levels at ultra-low dosea. We report a dose-ranging, randomized, doubla-
blind, placefm- (PLA) and positive-controlled multicentertrial for CER, in 939
patients with primaiy hypercholesterolemia. Patients received an AHA Step
1 diet for 10 weeks before randomization to either CER at doses of 0.05 mg,
0.1 mg, 0.2 mg or 0.3 mg, Iovastatin (LOV) 40 mg, or PLA; all once daily
for 24 weeks. LDL-cholesterol (C), total-C, HDL-C and triglycerides were
measured at every visit. Changes (% from baseline) in lipids at endpoint (up
to 24 weeks) were:
PLA CER CER CER CER LOV
0.05 mg 0.1 mg 0.2 mg 0,3 mg 40 mg
LDL-C +l.9– 13.5” –16.9* –25.6’ –28.5”
Total-C
–33.3*
+1,7 –9.6* –12.9* –17.6* –19,9’ –23.8*
*P <0.001 comparedto placebo
CER at all doses was well tolerated. There was no difference in the
numbers of patients discontinuing therapy due to adverse events (CER
3.7%, LOV 3.9%, or PLA 3.9%). LDL-C was reduced by approximately 6%
upon doubling the CER dose suggesting that the dose range tested is on the
steep portion of the dose-response curve. CER at ultra-low doses, all at least
100 times lower than LOV, is effective and well tolerated in reducing LDL-C
in patienta with primary hypercholesterolemia.
D92193 CanLisinoprilimproveendothelialfunctioninhyperlipidaemica?
A.F.C. Lee, J.B.C. Dick’, A.D. Struthers. Department of C/inica/
Pharmacology, University of Dundee, Dundee, DD19SX UK, 1Department
of Medicine, University of Dundee, Dundee. DD19SY UK
Endothelial function has been shown to be defective in hyperlipidaemic pa-
tients, and improvement can be demonstrated following dietary and drug
treatment. Animal studies have suggested that Angiotensin Converting En-
zyme (ACE) inhibitors may also improve endothelial functional. We aaaesaed
the effect of six months treatment with Iisinopril 20 mg/day on endothelial
function in a group of treated hyperlipidaemic patients. Methods: 40 patienta
were recruited. Baseline forearm venous occlusion piethysmography was
performed using acetylcholine (ACH) 7.5 @rein, 15 wg.rmin,30 wg/min, as
a endothelial dependent vasodilator, and sodium nitroprusside (NPR) 0.8
#g/ml, 1.6 ~g/ml and 3.2 #g/ml as an endothelial independent vaaodila-
tor. Subjects were randomised double blindly to receive either Lisinopril 20
mg/day (n = 20), or matched placebo (n = 20) for 6 months. After 6 months
treatment, plethsymography was repeated, using the same infusions. Ffe-
su/ts: Baseline variables (age, sex, blood pressure, weight, total chol) be-
tween groups were comparable. Cholesterol was unchanged. Active: Blood
pressure fell significantly, systolic 145 + 4 vs 129 + 4 (P < 0.0001), diastolic
83 + 2 vs 74 + 2 mmHg (P < 0.0001). An improvement was found in the
vasodilatory response (expressed as the ratio between the blood flow in the
infused arm against the control uninfused arm) to ACH (eg 4.45 + 0.48 vs
3.33 & 0.3 for ACH at 30 fi~min P < 0.03) and also for htPR (eg 3.88&
0.3 vs 3.0 + 0.2 at 3.2 wglmin P < 0.01). Placebo: ,Vasodiiatation deteri-
orated in response to ACH, with significance at one d08e only, but that to
NPR was unchanged. Conclusion.’The data presented are consistent with
Lisinopril having a beneficial effect on arterial function in hyperlipidaemic
patients.
D92194 TotalSerumCholesteroliathe beatPredictorforEndothelialDysfunctionin InternalMammary
ArterieeofCoronaryBypasaPatiente
A.A. Voors, M. Oosterga, H. Buikema, Y.M. Pinto, J.G. Grandjean,
W.J. Morehuis, J.H. Kingma, W.H. van Gilst. Universifyof Groningen & St.
Antonius Hospital Nieuwegein, the ~etherfands
To establish whether serum lipid levels could predict endothelial dysfunction
in internal mammary arteries (lMA’s) of coronary bypass patients, we mea-
suredfasting total cholesterol, triglycerides, HDL-cholesterol, LDL-cholesterol
and apoB within 4 weeks prior to surgery. During surgery, segments of the
IMA’s were obtained a6 excess graft material, and mounted in organ baths.
Rings of these artery segments were contracted to 10 WM phenylephrine
(PE), followed by increasing doses of metacholine (ME) (10 nM-100 wM),
